The CEO of Boston Scientific has publicly slammed the proposed $4bn annual tax on medical device makers that will help pay for the overhaul of the US healthcare system, claiming that its share of the hefty fee will lead to the company having to slash up to 2,000 jobs. Speaking at an ...
Please Login to read the full article.
